Loss of estrogen receptor in recurrent breast cancer is associated with poor response to endocrine therapy. The BSA-based method of dose calculation was adopted without adequate investigation of its ...

LAP is majoring on functional and commercial innovation with the roll-out of automated 3D dose verification and a new subscription licensing model for its RadCalc QA software Second check: RadCalc’s ...